FI963638A - Förfaranden för diagnostisering och behandling av HIV-1-infektion - Google Patents

Förfaranden för diagnostisering och behandling av HIV-1-infektion Download PDF

Info

Publication number
FI963638A
FI963638A FI963638A FI963638A FI963638A FI 963638 A FI963638 A FI 963638A FI 963638 A FI963638 A FI 963638A FI 963638 A FI963638 A FI 963638A FI 963638 A FI963638 A FI 963638A
Authority
FI
Finland
Prior art keywords
hiv
infection
diagnosis
procedures
treatment
Prior art date
Application number
FI963638A
Other languages
English (en)
Finnish (fi)
Other versions
FI963638A0 (sv
Inventor
Angeline Douvas
Glenn Ehresmann
Yoshi Takehana
Original Assignee
Univ Southern California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Southern California filed Critical Univ Southern California
Publication of FI963638A0 publication Critical patent/FI963638A0/sv
Publication of FI963638A publication Critical patent/FI963638A/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Rehabilitation Therapy (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI963638A 1994-03-14 1996-09-13 Förfaranden för diagnostisering och behandling av HIV-1-infektion FI963638A (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21374394A 1994-03-14 1994-03-14
PCT/US1995/003236 WO1995025124A1 (en) 1994-03-14 1995-03-13 Methods to diagnose and treat hiv-1 infection

Publications (2)

Publication Number Publication Date
FI963638A0 FI963638A0 (sv) 1996-09-13
FI963638A true FI963638A (sv) 1996-11-13

Family

ID=22796323

Family Applications (1)

Application Number Title Priority Date Filing Date
FI963638A FI963638A (sv) 1994-03-14 1996-09-13 Förfaranden för diagnostisering och behandling av HIV-1-infektion

Country Status (6)

Country Link
EP (1) EP0750636A1 (sv)
JP (1) JPH10504798A (sv)
CA (1) CA2185129A1 (sv)
FI (1) FI963638A (sv)
NO (1) NO963848L (sv)
WO (1) WO1995025124A1 (sv)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1141314A2 (en) 1998-12-31 2001-10-10 Chiron Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
AU2002320314A1 (en) 2001-07-05 2003-01-21 Chiron, Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
US20030186849A1 (en) * 2001-09-06 2003-10-02 Zimmer Robert H. Modified peptides and their use for the treatment of autoimmune diseases
CN101588813A (zh) * 2005-04-12 2009-11-25 杜克大学 诱导人类免疫缺陷病毒的中和抗体的方法
AU2006235507B2 (en) * 2005-04-12 2012-08-30 Duke University Method of inducing neutralizing antibodies to human immunodeficiency virus
US8956627B2 (en) 2007-04-13 2015-02-17 Duke University Method of inducing antibodies to human immunodeficiency virus involving the administration of MPER peptide-liposome conjugates
EP2413951A4 (en) 2009-04-03 2015-05-20 Univ Duke FORMULATION FOR GENERATING A WIDE REACTIVE NEUTRALIZATION OF HIV ANTIBODIES
WO2015048635A1 (en) 2013-09-27 2015-04-02 Duke University Mper-liposome conjugates and uses thereof
US10213482B2 (en) 2014-12-12 2019-02-26 Immupharma France Sa Methods of treating chronic inflammatory diseases

Also Published As

Publication number Publication date
AU694204B2 (en) 1998-07-16
WO1995025124A1 (en) 1995-09-21
JPH10504798A (ja) 1998-05-12
NO963848D0 (no) 1996-09-13
EP0750636A1 (en) 1997-01-02
CA2185129A1 (en) 1995-09-21
NO963848L (no) 1996-11-14
AU2120595A (en) 1995-10-03
FI963638A0 (sv) 1996-09-13

Similar Documents

Publication Publication Date Title
FI952926A0 (sv) Förfaranden för behandling och förebyggande av allFörfaranden för behandling och förebyggande av allergies ergies
FI971969A (sv) Kompositioner för behandling av hemorrojder och användningsmetod
NO952573D0 (no) Blandinger for behandling av diabetiske komplikasjoner
FI963281A (sv) Ureasbaserat vaccin och behandling av helicobakterieinfektion
DE69822410D1 (de) Modularkatheter zur Abbildung und Behandlung und Montageverfahren
FI970918A0 (sv) Föreningar och förfarande för behandling av cancer
FI94028B (sv) Anordning för diagnos och vård av nässjukdomar
FI19992398A (sv) Förfarande och arrangemang för identifiering av hjärtslag
DE69115626D1 (de) Medizinisches Gerät für endoskopische Chirurgie
FI951370A (sv) Tiazolidin- och oxazolidinderivat, deras framställning och deras medicinska användning
DE69635364D1 (de) Blutfilter und extrakorporaler Kreislauf
FI971568A (sv) Förfarande för behandling av resistenta tumörer
FI965204A (sv) Medicinsk användning av bromelain
DE69603635T2 (de) Katheterstruktur für medizinische Behandlung
DE69620691T2 (de) Therapeutisches Mittel zur Behandlung der Hypercholesterinämie
BR9101494A (pt) Tratamento de tecidos
FI963638A (sv) Förfaranden för diagnostisering och behandling av HIV-1-infektion
ATA113492A (de) Mehrfachbeutelsystem zur sterilen behandlung von menschlichen blutkonserven
FI971897A0 (sv) Detektering av human retrovirusinfektion
NO913117D0 (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
FI964113A0 (sv) Medicinsk sammansättning för behandling av tardiv dyskinesi och användning av densamma
NO965591D0 (no) Kombinasjonsbehandling av HIV-infeksjon
FI963947A0 (sv) Fullkomligt upplöst benvävnad och förfarande för framställning av densamma
FI963263A0 (sv) Medicinsk användning av bromelain
DE69737088D1 (de) Therapeutisches agens zur behandlung von fiv infektionen

Legal Events

Date Code Title Description
MA Patent expired